Title:
THERAPEUTIC AGENT FOR INDICATIONS FOR HALOPERIDOL, AND BEVERAGE OR FOOD
Document Type and Number:
WIPO Patent Application WO/2012/002522
Kind Code:
A1
Abstract:
Disclosed are: a therapeutic agent for indications for haloperidol, which comprises α-lactoalbumin as an active ingredient; a beverage or food which contains the therapeutic agent for indications for haloperidol; α-lactoalbumin for use in the treatment of indications for haloperidol; and a method for treating indications for haloperidol, which comprises administering an effective amount of α-lactoalbumin to a patient who needs the treatment. The therapeutic agent for indications for haloperidol is safe and can be used in a simple manner.
Inventors:
ORIKASA Shuzo (Food Science & Technology Institute, 1-83, Higashihara 5-chome, Zama-sh, Kanagawa 83, 〒2528583, JP)
Application Number:
JP2011/065140
Publication Date:
January 05, 2012
Filing Date:
July 01, 2011
Export Citation:
Assignee:
MORINAGA MILK INDUSTRY CO., LTD. (33-1, Shiba 5-chome Minato-k, Tokyo 84, 〒1088384, JP)
森永乳業株式会社 (〒84 東京都港区芝五丁目33番1号 Tokyo, 〒1088384, JP)
森永乳業株式会社 (〒84 東京都港区芝五丁目33番1号 Tokyo, 〒1088384, JP)
International Classes:
A61K38/00; A23L1/305; A61P25/00; A61P25/14; A61P25/18; A61P25/36; A61P43/00; C07K14/76
Attorney, Agent or Firm:
SHIGA Masatake et al. (1-9-2, Marunouchi Chiyoda-k, Tokyo 20, 〒1006620, JP)
Claims:
Previous Patent: PROCESS FOR PRODUCING VULCANIZED RUBBER COMPOSITION
Next Patent: PTC DEVICE AND SECONDARY BATTERY HAVING SAME
Next Patent: PTC DEVICE AND SECONDARY BATTERY HAVING SAME
